A team led by Harvard SEAS Postdoctoral Fellow Dr. John Zimmerman and including NTT Research Medical and Health Informatics Scientist Ryoma Ishii, Harvard SEAS Tarr Family Professor of Bioengineering ...

Did it feel good to see the Eagles win a Super Bowl? Or did it feel good to see the Chiefs lose a Super Bowl? Or both? What ...

There's growing evidence to suggest that GLP-1 drugs, which include semaglutide, may be useful for treating alcohol use disorder.

Our guts are home to trillions of bacteria, and research over the last few decades has established how essential they are to our physiology – in health and disease.

As many as 40% of Americans are obese, putting them at an increased risk for high blood pressure, diabetes, stroke, heart disease and certain cancers, according to the CDC.